Compare · head to head
Daewon Pharmaceutical vs Rohto Pharmaceutical
Rohto Pharmaceutical ranks higher overall — 360 rank 81 vs 46.
Daewon Pharmaceutical leads on Quality (59 vs 52). Rohto Pharmaceutical leads on Growth (56 vs 51) and Safety (61 vs 22). The two are close on Value and Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | Japan |
| Sector | Health Care | Home & Consumer Goods |
| Industry | Pharmaceuticals | Personal Products |
| Size | Small | Large |
| ISIN | KR7003220001 | JP3982400008 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 46 | 81 |
| Value | 55 | 59 |
| Quality | 59 | 52 |
| Growth | 51 | 56 |
| Safety | 22 | 61 |
| Sentiment | 59 | 55 |
| Quality details | ||
| Profitability | 64 | 51 |
| Cash Truth | 53 | 54 |
Daewon Pharmaceutical vs Towa PharmaceuticalDaewon Pharmaceutical vs Reyon PharmaceuticalDaewon Pharmaceutical vs Il Dong PharmaceuticalDaewon Pharmaceutical vs PharmGen ScienceAdd a third stock →
Full analyses: Daewon Pharmaceutical · Rohto Pharmaceutical
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100